Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to $488372.0.

  • Neuphoria Therapeutics' Receivables - Other rose 2406486.89% to $488372.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $488372.0, marking a year-over-year increase of 2406486.89%. This contributed to the annual value of $237.0 for FY2025, which is N/A changed from last year.
  • Neuphoria Therapeutics' Receivables - Other amounted to $488372.0 in Q4 2025, which was up 2406486.89% from $1758.0 recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Receivables - Other registered a high of $4.8 million during Q2 2022, and its lowest value of $237.0 during Q2 2025.
  • Its 5-year average for Receivables - Other is $736443.8, with a median of $100625.0 in 2024.
  • Over the last 5 years, Neuphoria Therapeutics' Receivables - Other had its largest YoY gain of 2406486.89% in 2025, and its largest YoY loss of 9825.29% in 2025.
  • Quarter analysis of 5 years shows Neuphoria Therapeutics' Receivables - Other stood at $799485.9 in 2021, then surged by 502.03% to $4.8 million in 2022, then crashed by 91.29% to $419435.6 in 2023, then plummeted by 99.52% to $2021.0 in 2024, then surged by 24064.87% to $488372.0 in 2025.
  • Its last three reported values are $488372.0 in Q4 2025, $1758.0 for Q3 2025, and $237.0 during Q2 2025.